R01 DK117657/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2018	4
2019	6
2020	2
2021	4
2022	6
2023	7
2024	3

1

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus.

Ferguson D, Finck BN. Ferguson D, et al. Nat Rev Endocrinol. 2021 Aug;17(8):484-495. doi: 10.1038/s41574-021-00507-z. Epub 2021 Jun 15. Nat Rev Endocrinol. 2021. PMID: 34131333 Free PMC article. Review.

2

The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism.

Yiew NKH, Finck BN. Yiew NKH, et al. Am J Physiol Endocrinol Metab. 2022 Jul 1;323(1):E33-E52. doi: 10.1152/ajpendo.00074.2022. Epub 2022 May 30. Am J Physiol Endocrinol Metab. 2022. PMID: 35635330 Free PMC article. Review.

3

Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism.

Ferguson D, Eichler SJ, Yiew NKH, Colca JR, Cho K, Patti GJ, Shew TM, Lutkewitte AJ, Mukherjee S, McCommis KS, Niemi NM, Finck BN. Ferguson D, et al. Mol Metab. 2023 Apr;70:101694. doi: 10.1016/j.molmet.2023.101694. Epub 2023 Feb 18. Mol Metab. 2023. PMID: 36801448 Free PMC article. Clinical Trial.

4

Something to mTORC About in NASH.

Finck BN. Finck BN. Cell Mol Gastroenterol Hepatol. 2022;13(6):1843-1844. doi: 10.1016/j.jcmgh.2022.03.001. Epub 2022 Apr 2. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35378066 Free PMC article. No abstract available.

5

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism.

McCommis KS, Finck BN. McCommis KS, et al. Cell Mol Gastroenterol Hepatol. 2019;7(2):275-284. doi: 10.1016/j.jcmgh.2018.09.017. Epub 2018 Oct 10. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30686780 Free PMC article. Review.

6

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis.

Finck BN. Finck BN. Diabetes. 2018 Dec;67(12):2485-2493. doi: 10.2337/dbi18-0024. Diabetes. 2018. PMID: 30459251 Free PMC article. Review.

7

Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult.

Yiew NKH, Vazquez JH, Martino MR, Kennon-McGill S, Price JR, Allard FD, Yee EU, Layman AJ, James LP, McCommis KS, Finck BN, McGill MR. Yiew NKH, et al. Mol Metab. 2023 Nov;77:101808. doi: 10.1016/j.molmet.2023.101808. Epub 2023 Sep 15. Mol Metab. 2023. PMID: 37716594 Free PMC article.

8

Targeting hepatocyte carbohydrate transport to mimic fasting and calorie restriction.

Kading J, Finck BN, DeBosch BJ. Kading J, et al. FEBS J. 2021 Jun;288(12):3784-3798. doi: 10.1111/febs.15482. Epub 2020 Jul 26. FEBS J. 2021. PMID: 32654397 Free PMC article. Review.

9

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice.

Yiew NKH, Deja S, Ferguson D, Cho K, Jarasvaraparn C, Jacome-Sosa M, Lutkewitte AJ, Mukherjee S, Fu X, Singer JM, Patti GJ, Burgess SC, Finck BN. Yiew NKH, et al. iScience. 2023 Oct 12;26(11):108196. doi: 10.1016/j.isci.2023.108196. eCollection 2023 Nov 17. iScience. 2023. PMID: 37942005 Free PMC article.

10

Fatty Acid Desaturation Gets a NAD⁺ Reputation.

Lutkewitte AJ, Burgess SC, Finck BN. Lutkewitte AJ, et al. Cell Metab. 2019 Apr 2;29(4):790-792. doi: 10.1016/j.cmet.2019.03.007. Cell Metab. 2019. PMID: 30943390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year